Ponatinib 15/30 mg Tablets in India for Targeted Cancer Therapy
- Contact No: 09007090388
- Email ID: [email protected]
- Website: https://medium.com/@impomed211/ponatinib-15-30-mg-tablets-in-india-hope-for-patients-with-drug-resistant-cml-a957bbeee133
- City: Ahmedabad
- State: Gujarat
- Zip/Postal Code: 380024
- Country: India
- Listed: October 29, 2024 5:11 am
- Expires: 13 days, 12 hours
Description
Ponatinib 15/30 mg tablets play a vital role in targeted cancer therapy, particularly for chronic myeloid leukemia (CML) patients who possess resistant gene mutations. By inhibiting BCR-ABL tyrosine kinase mutations, including the difficult-to-treat T315I mutation, Ponatinib offers hope for those with limited treatment options. Ponatinib 15 / 30 mg in India, provides targeted action with improved outcomes. This innovative treatment is made accessible through Impomed Healthcare, supporting patients needing advanced cancer care solutions.
For more information visit:-https://www.impomedhealthcare.com
15 total views, 1 today